Abstract:Background FBI-1 ( f actor that b inds to the i nducer of short transcripts of human immunodeficiency virus- 1 ) is a member of the POK (POZ and Kruppel) family of transcription factors and play important roles in cellular differentiation and oncogenesis. Recent evidence suggests that FBI-1 is expressed at high levels in a subset of human lymphomas and some epithelial solid tumors. However, the function of FBI-1 in human ovarian cancers remains elusive. Results In this study, we investigated the role of FBI-1 in human ovarian cancers, in particularly, its function in cancer cell invasion via modulating membrane type 1-matrix metalloproteinase (MT1-MMP). Significantly higher FBI-1 protein and mRNA expression levels were demonstrated in ovarian cancers samples and cell lines compared with borderline tumors and benign cystadenomas. Increased FBI-1 mRNA expression was correlated significantly with gene amplification (P = 0.037). Moreover, higher FBI-1 expression was found in metastatic foci (P = 0.036) and malignant ascites (P = 0.021), and was significantly associated with advanced stage (P = 0.012), shorter overall survival (P = 0.032) and disease-free survival (P = 0.016). In vitro , overexpressed FBI-1 significantly enhanced cell migration and invasion both in OVCA 420 and SKOV-3 ovarian carcinoma cells, irrespective of p53 status, accompanied with elevated expression of MT1-MMP, but not MMP-2 or TIMP-2. Moreover, knockdown of MT1-MMP abolished FBI-1-mediated cell migration and invasion. Conversely, stable knockdown of FBI-1 remarkably reduced the motility of these cells with decreased expression of MT1-MMP. Promoter assay and chromatin immunoprecipitation study indicated that FBI-1 could directly interact with the promoter spanning ~600bp of the 5'-flanking sequence of MT1-MMP and enhanced its expression in a dose-dependent manner. Furthermore, stable knockdown and ectopic expression of FBI-1 decreased and increased cell proliferation respectively in OVCA 420, but not in the p53 null SKOV-3 cells. Conclusions Our results suggested an important role of FBI-1 in ovarian cancer cell proliferation, cell mobility, and invasiveness, and that FBI-1 can be a potential target of chemotherapy.

Overexpression of Proto-Oncogene FBI-1 Activates Membrane Type 1-Matrix Metalloproteinase in Association with Adverse Outcome in Ovarian Cancers

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.

Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/SRC pathway

FBI-1 Enhances ETS-1 Signaling Activity and Promotes Proliferation of Human Colorectal Carcinoma Cells

Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.

Overexpression of FOXM1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation, Migration and Invasion in Epithelial Ovarian Cancer.

Intensive Expression of Bmi-1 is a New Independent Predictor of Poor Outcome in Patients with Ovarian Carcinoma

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

Oncogenic Fli-1 is a Potential Prognostic Marker for the Progression of Epithelial Ovarian Cancer

High FAM111B expression predicts aggressive clinicopathologic features and poor prognosis in ovarian cancer

Fibrillin-1, Induced By Aurora-A But Inhibited By Brca2, Promotes Ovarian Cancer Metastasis

Targeting HMGB1 Inhibits Ovarian Cancer Growth and Metastasis by Lentivirus‐mediated RNA Interference

The Transcription Factor FOXA1 Induces Epithelial Ovarian Cancer Tumorigenesis and Progression

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

MPZL1 Promotes Tumor Cell Proliferation and Migration Via Activation of Src Kinase in Ovarian Cancer.

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma

MOB Kinase Activator 1A Acts As an Oncogene by Targeting PI3K/AKT/mTOR in Ovarian Cancer

PPM1F regulates ovarian cancer progression by affecting the dephosphorylation of ITGB1

Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness

Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer.